Symbols / CYDY $0.37 +2.78% CytoDyn Inc.

Healthcare • Biotechnology • United States • OQB
CYDY Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. It has a collaboration with Creatv Bio. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

Fundamentals
Scroll to Statements
Market Cap 505.43M Enterprise Value 478.84M Income -40.28M Sales — Book/sh -0.08 Cash/sh 0.01
Dividend Yield — Payout 0.00% Employees 13 IPO — P/E — Forward P/E -2.06
PEG — P/S — P/B -4.81 P/C — EV/EBITDA -22.38 EV/Sales —
Quick Ratio 0.31 Current Ratio 0.37 Debt/Eq — LT Debt/Eq — EPS (ttm) -0.04 EPS next Y -0.18
EPS Growth — Revenue Growth — Earnings 2026-04-08 ROA -67.45% ROE — ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 1.37B Shs Float 1.37B Short Float —
Short Ratio — Short Interest — 52W High 0.45 52W Low 0.21 Beta 1.17 Avg Volume 1.84M
Volume 4.56M Target Price — Recom None Prev Close $0.36 Price $0.37 Change 2.78%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.34
Latest analyst target
3. DCF / Fair value
$-0.06
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.34
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2020-07-06 down HC Wainwright & Co. Buy → Neutral —
2020-04-28 reit HC Wainwright & Co. — → Buy $4
2020-04-03 reit HC Wainwright & Co. — → Buy $3
2019-12-19 reit HC Wainwright & Co. — → Buy $2
2019-09-16 reit HC Wainwright & Co. — → Buy $1
News
RSS: Latest CYDY news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Total Revenue
0.00
0.00
0.00
-100.00%
0.27
Operating Revenue
0.00
0.00
0.00
-100.00%
0.27
Cost Of Revenue
—
0.00
-100.00%
20.63
+38830.19%
0.05
Reconciled Cost Of Revenue
—
0.00
-100.00%
20.63
+38830.19%
0.05
Gross Profit
—
0.00
+100.00%
-20.63
-9786.85%
0.21
Operating Expense
-9.66
-153.50%
18.06
-9.45%
19.94
-86.30%
145.62
Research And Development
-16.92
-333.72%
7.24
+175.08%
2.63
-90.27%
27.04
Selling General And Administration
7.26
-32.89%
10.82
-36.87%
17.14
-61.32%
44.30
General And Administrative Expense
7.26
-32.89%
10.82
-36.87%
17.14
-61.32%
44.30
Salaries And Wages
2.38
-51.65%
4.92
-40.95%
8.34
-33.84%
12.60
Other Gand A
3.64
-10.01%
4.05
-36.79%
6.40
-76.46%
27.19
Other Operating Expenses
—
—
20.63
-71.92%
73.49
Total Expenses
-9.66
-153.50%
18.06
-55.50%
40.58
-72.15%
145.67
Operating Income
9.66
+153.50%
-18.06
+55.50%
-40.58
+72.09%
-145.40
Total Operating Income As Reported
-9.66
+46.50%
-18.06
+55.50%
-40.58
+72.09%
-145.40
EBITDA
8.59
+119.50%
-44.08
+39.54%
-72.90
+62.61%
-194.97
Normalized EBITDA
9.04
+129.67%
-30.47
+52.51%
-64.15
+66.44%
-191.12
Reconciled Depreciation
0.02
-37.93%
0.03
-83.43%
0.17
-77.59%
0.78
EBIT
8.58
+119.44%
-44.11
+39.64%
-73.07
+62.67%
-195.75
Total Unusual Items
-0.45
+96.73%
-13.61
-55.54%
-8.75
-127.10%
-3.85
Total Unusual Items Excluding Goodwill
-0.45
+96.73%
-13.61
-55.54%
-8.75
-127.10%
-3.85
Special Income Charges
0.41
+103.04%
-13.37
0.00
+100.00%
-3.85
Other Special Charges
—
13.37
—
3.85
Impairment Of Capital Assets
—
—
—
0.00
Restructuring And Mergern Acquisition
-0.41
0.00
—
—
Write Off
—
—
—
73.49
Net Income
3.75
+107.51%
-49.84
+37.56%
-79.82
+62.14%
-210.82
Pretax Income
3.75
+107.51%
-49.84
+37.56%
-79.82
+62.14%
-210.82
Net Non Operating Interest Income Expense
-5.47
+69.89%
-18.17
+40.41%
-30.50
+50.46%
-61.56
Interest Expense Non Operating
4.83
-15.76%
5.74
-15.04%
6.75
-55.20%
15.07
Net Interest Income
-5.47
+69.89%
-18.17
+40.41%
-30.50
+50.46%
-61.56
Interest Expense
4.83
-15.76%
5.74
-15.04%
6.75
-55.20%
15.07
Interest Income Non Operating
0.56
+160.37%
0.22
—
—
Interest Income
0.56
+160.37%
0.22
—
—
Other Income Expense
-0.45
+96.73%
-13.61
-55.54%
-8.75
-127.10%
-3.85
Gain On Sale Of Security
-0.85
-261.02%
-0.24
+97.30%
-8.75
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
3.75
+107.51%
-49.84
+37.56%
-79.82
+62.14%
-210.82
Net Income From Continuing Operation Net Minority Interest
3.75
+107.51%
-49.84
+37.56%
-79.82
+62.14%
-210.82
Net Income From Continuing And Discontinued Operation
3.75
+107.51%
-49.84
+37.56%
-79.82
+62.14%
-210.82
Net Income Continuous Operations
3.75
+107.51%
-49.84
+37.56%
-79.82
+62.14%
-210.82
Normalized Income
4.19
+111.56%
-36.23
+49.02%
-71.07
+65.66%
-206.97
Net Income Common Stockholders
—
—
—
—
Otherunder Preferred Stock Dividend
—
0.00
-100.00%
5.42
0.00
Diluted EPS
0.00
+100.00%
-0.05
+50.00%
-0.10
+67.74%
-0.31
Basic EPS
0.00
+100.00%
-0.05
+50.00%
-0.10
+67.74%
-0.31
Basic Average Shares
1,205.76
+24.37%
969.51
+15.90%
836.53
+23.58%
676.90
Diluted Average Shares
1,242.92
+28.20%
969.51
+15.90%
836.53
+23.58%
676.90
Diluted NI Availto Com Stockholders
2.26
+104.41%
-51.32
+40.83%
-86.74
+59.17%
-212.45
Amortization
—
0.00
-100.00%
0.13
—
Amortization Of Intangibles Income Statement
—
0.00
-100.00%
0.13
—
Depreciation Amortization Depletion Income Statement
—
0.03
-83.43%
0.17
-77.59%
0.78
Depreciation And Amortization In Income Statement
—
0.03
-83.43%
0.17
-77.59%
0.78
Depreciation Income Statement
—
0.03
-32.56%
0.04
—
Insurance And Claims
1.24
-33.03%
1.85
-22.88%
2.40
-46.83%
4.51
Preferred Stock Dividends
1.48
+0.00%
1.48
-0.80%
1.50
-8.17%
1.63
Total Other Finance Cost
1.21
-90.48%
12.65
-46.71%
23.75
-48.93%
46.50
Line Item Trend 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Total Assets
18.05
+62.06%
11.14
-1.38%
11.29
-61.31%
29.18
Current Assets
17.88
+65.31%
10.81
+0.09%
10.80
+2.76%
10.52
Cash Cash Equivalents And Short Term Investments
11.90
+282.73%
3.11
+22.39%
2.54
-39.94%
4.23
Cash And Cash Equivalents
11.90
+282.73%
3.11
+22.39%
2.54
-39.94%
4.23
Cash Financial
11.90
+282.73%
3.11
+22.39%
2.54
-39.94%
4.23
Receivables
2.00
0.00
—
—
Other Receivables
2.00
—
—
—
Inventory
—
—
—
17.93
Raw Materials
—
—
—
16.26
Work In Process
—
—
—
1.67
Prepaid Assets
3.98
+297.10%
1.00
-43.03%
1.76
-72.04%
6.28
Restricted Cash
0.00
-100.00%
6.70
+3.03%
6.51
0.00
Total Non Current Assets
0.17
-47.35%
0.32
-34.09%
0.49
-97.41%
18.80
Net PPE
—
—
—
0.61
Gross PPE
—
—
—
0.61
Other Properties
—
—
—
0.61
Goodwill And Other Intangible Assets
—
—
0.00
-100.00%
0.13
Other Intangible Assets
—
—
—
0.13
Other Non Current Assets
0.17
-47.35%
0.32
-34.09%
0.49
-97.39%
18.67
Total Liabilities Net Minority Interest
114.09
-10.79%
127.89
+5.88%
120.79
-2.26%
123.58
Current Liabilities
70.52
-16.23%
84.18
-29.73%
119.80
-2.73%
123.16
Payables And Accrued Expenses
42.75
-20.85%
54.01
-36.32%
84.83
-0.44%
85.20
Payables
22.96
-36.84%
36.35
-46.57%
68.03
-5.45%
71.95
Accounts Payable
14.69
-50.30%
29.56
-52.87%
62.73
-7.72%
67.97
Other Payable
—
—
0.14
+3.73%
0.13
Dividends Payable
8.27
+21.76%
6.79
+27.94%
5.31
+33.47%
3.98
Current Accrued Expenses
19.79
+12.07%
17.66
+5.17%
16.79
+26.75%
13.25
Pensionand Other Post Retirement Benefit Plans Current
0.28
+33.65%
0.21
-37.91%
0.34
-77.99%
1.52
Current Debt And Capital Lease Obligation
27.34
-8.67%
29.93
-13.37%
34.56
-5.00%
36.38
Current Debt
27.20
-8.70%
29.79
-13.44%
34.42
-5.03%
36.24
Other Current Borrowings
27.20
-8.70%
29.79
-13.44%
34.42
-5.03%
36.24
Current Capital Lease Obligation
0.14
-0.70%
0.14
+2.16%
0.14
+3.73%
0.13
Other Current Liabilities
0.14
+480.00%
0.03
-68.35%
0.08
+23.44%
0.06
Total Non Current Liabilities Net Minority Interest
43.57
-0.32%
43.71
+4284.35%
1.00
+136.26%
0.42
Long Term Debt And Capital Lease Obligation
0.00
-100.00%
0.14
-85.86%
1.00
+136.26%
0.42
Long Term Debt
—
—
0.71
—
Long Term Capital Lease Obligation
0.00
-100.00%
0.14
-50.18%
0.28
-32.94%
0.42
Other Non Current Liabilities
43.57
+0.00%
43.57
—
—
Stockholders Equity
-96.04
+17.74%
-116.76
-6.63%
-109.50
-16.00%
-94.40
Common Stock Equity
-96.04
+17.74%
-116.76
-6.63%
-109.50
-16.00%
-94.40
Capital Stock
1.25
+17.94%
1.06
+15.23%
0.92
+27.64%
0.72
Common Stock
1.25
+17.94%
1.06
+15.23%
0.92
+27.64%
0.72
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
1,249.46
+17.98%
1,059.00
+15.23%
919.05
+27.64%
720.03
Ordinary Shares Number
1,249.17
+18.01%
1,058.56
+15.23%
918.61
+27.66%
719.59
Treasury Shares Number
0.29
-35.44%
0.44
+0.00%
0.44
+0.00%
0.44
Additional Paid In Capital
790.50
+2.17%
773.71
+5.80%
731.27
+8.98%
671.01
Retained Earnings
-887.79
+0.42%
-891.53
-5.92%
-841.69
-9.86%
-766.13
Treasury Stock
0.00
0.00
0.00
0.00
Total Equity Gross Minority Interest
-96.04
+17.74%
-116.76
-6.63%
-109.50
-16.00%
-94.40
Total Capitalization
-96.04
+17.74%
-116.76
-7.33%
-108.79
-15.24%
-94.40
Working Capital
-52.64
+28.25%
-73.37
+32.69%
-108.99
+3.24%
-112.65
Invested Capital
-68.84
+20.84%
-86.97
-16.94%
-74.37
-27.88%
-58.16
Total Debt
27.34
-9.09%
30.08
-15.41%
35.55
-3.38%
36.80
Net Debt
15.30
-42.67%
26.68
-18.13%
32.59
+1.81%
32.01
Capital Lease Obligations
0.14
-50.18%
0.28
-32.94%
0.42
-24.10%
0.56
Net Tangible Assets
-96.04
+17.74%
-116.76
-6.63%
-109.50
-15.84%
-94.53
Tangible Book Value
-96.04
+17.74%
-116.76
-6.63%
-109.50
-15.84%
-94.53
Interest Payable
18.15
+19.20%
15.23
+43.68%
10.60
+77.40%
5.97
Line Item Trend 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Operating Cash Flow
-8.77
+20.19%
-10.98
+56.26%
-25.11
+67.69%
-77.72
Cash Flow From Continuing Operating Activities
-8.77
+20.19%
-10.98
+56.26%
-25.11
+67.69%
-77.72
Net Income From Continuing Operations
3.75
+107.51%
-49.84
+37.56%
-79.82
+62.14%
-210.82
Depreciation Amortization Depletion
0.02
-37.93%
0.03
-83.43%
0.17
-77.59%
0.78
Depreciation
0.02
-37.93%
0.03
-32.56%
0.04
—
Amortization Cash Flow
—
0.00
-100.00%
0.13
—
Depreciation And Amortization
0.02
-37.93%
0.03
-83.43%
0.17
-77.59%
0.78
Amortization Of Intangibles
—
0.00
-100.00%
0.13
—
Other Non Cash Items
—
4.47
-88.05%
37.39
+87.10%
19.98
Stock Based Compensation
1.61
-33.25%
2.42
-43.51%
4.28
-31.48%
6.24
Asset Impairment Charge
—
—
20.63
-71.92%
73.49
Deferred Tax
—
—
—
—
Deferred Income Tax
—
—
—
—
Operating Gains Losses
2.03
-89.99%
20.29
+44.23%
14.07
-62.37%
37.38
Gain Loss On Investment Securities
0.85
+261.02%
0.24
-97.30%
8.76
—
Net Foreign Currency Exchange Gain Loss
1.18
-82.34%
6.68
+25.75%
5.31
-85.79%
37.38
Change In Working Capital
-16.17
-238.72%
11.66
+1075.56%
-1.20
+74.99%
-4.78
Change In Receivables
—
—
—
0.00
Change In Inventory
—
—
0.00
-100.00%
2.06
Change In Prepaid Assets
-4.84
-641.99%
0.89
-53.05%
1.90
+146.11%
-4.12
Change In Payables And Accrued Expense
-11.33
-205.27%
10.77
+447.59%
-3.10
-14.15%
-2.71
Investing Cash Flow
0.00
0.00
0.00
0.00
Cash Flow From Continuing Investing Activities
—
—
—
0.00
Net PPE Purchase And Sale
—
—
—
0.00
Purchase Of PPE
—
—
—
0.00
Capital Expenditure
—
—
—
—
Net Intangibles Purchase And Sale
—
—
—
—
Purchase Of Intangibles
—
—
—
—
Financing Cash Flow
10.85
-7.61%
11.75
-60.74%
29.93
-37.67%
48.01
Cash Flow From Continuing Financing Activities
10.85
-7.61%
11.75
-60.74%
29.93
-37.67%
48.01
Net Issuance Payments Of Debt
-0.71
-135.31%
2.01
+124.69%
0.90
0.00
Issuance Of Debt
0.00
-100.00%
2.01
+124.69%
0.90
0.00
Repayment Of Debt
-0.71
0.00
—
0.00
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Short Term Debt Issuance
0.00
-100.00%
2.01
+124.69%
0.90
—
Short Term Debt Payments
-0.71
0.00
—
—
Net Short Term Debt Issuance
-0.71
-135.31%
2.01
+124.69%
0.90
—
Net Common Stock Issuance
0.00
-100.00%
9.14
-64.57%
25.79
-37.41%
41.20
Cash Dividends Paid
—
—
—
0.00
Proceeds From Stock Option Exercised
11.56
+3754.67%
0.30
-90.76%
3.25
-52.38%
6.82
Net Other Financing Charges
—
0.30
—
—
Changes In Cash
2.09
+172.72%
0.77
-84.10%
4.82
+116.21%
-29.71
Beginning Cash Position
9.81
+8.47%
9.05
+113.85%
4.23
-87.53%
33.94
End Cash Position
11.90
+21.29%
9.81
+8.47%
9.05
+113.85%
4.23
Free Cash Flow
-8.77
+20.19%
-10.98
+56.26%
-25.11
+67.69%
-77.72
Interest Paid Supplemental Data
0.03
-44.44%
0.04
+136.84%
0.02
-69.84%
0.06
Common Stock Issuance
0.00
-100.00%
9.14
-64.57%
25.79
-37.41%
41.20
Issuance Of Capital Stock
0.00
-100.00%
9.14
-64.57%
25.79
-37.41%
41.20
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Dividend Paid
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category